Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Use Of Mifepristone After Progestin Priming For Use As "Missed Period Pills"

NCT04676776 is registered in ClinicalTrials.gov with Gynuity Health Projects as lead sponsor.

NCT NCT04676776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04676776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Use Of Mifepristone After Progestin Priming For Use As "Missed Period Pills"
Lead sponsor
Gynuity Health Projects
Phase
Phase 2
Overall status
Unknown status
Start date
January 25, 2021
Completion date
December 31, 2021
Enrollment
139 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

missed menstrual period